Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs

Google DeepMind’s chief business officer says Alphabet’s drug-discovery company Isomorphic Labs “is preparing to launch human trials of AI-designed drugs,” according to a report in Fortune, “pairing cutting-edge AI with pharma veterans to design medicines faster, cheaper, and more accurately.” “There are people sitting in our office in King’s Cross, Read more…